MgO@SiO2纳米囊:一种可控的离子释放系统,用于有针对性的抑制骨关节炎进展
Na Liu1, Fangchao Jiang2, Zhizi Feng2
1Affiliated Xinhua Hospital of Dalian University Dalian Liaoning 116000 China zhn1979-08@163.com.
Nanoscale advances
|February 6, 2025
概括
这项研究开发了MgO@SiO2纳米颗粒用于控制释放,有效治疗子骨关节炎 (OA). 这种新型的输送系统增强了离子疗法的疗效.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 整形外科 整形外科 整形外科
背景情况:
- 骨关节炎 (OA) 是一种带有慢性炎症的退行性关节疾病.
- 在关节内 (i.a.) 盐注射显示了对OA的治疗潜力.
- 由于快速离子扩散,目前的疗法的有效性有限.
研究的目的:
- 开发一种纳米粒子输送系统,用于持续的关节内释放.
- 在OA模型中评估MgO@SiO2纳米颗粒的治疗疗效和安全性.
- 研究OA软骨中MgO@SiO2纳米囊的抗炎机制.
主要方法:
- MgO@SiO2核心/外纳米颗粒的制造和表征.
- 在体外离子释放研究.
- 在子OA模型中的体内评估,包括组织学和免疫组织化学分析.
主要成果:
- MgO@SiO2纳米粒子在72小时以上的时间内表现出受控的释放.
- 纳米囊的关节内注射在四周内显著降低了子的OA进展.
- 没有观察到系统性毒性.
- 纳米颗粒抑制了NF-κB/p65信号传递,缓解了OA软骨中的炎症.
结论:
- MgO@SiO2纳米颗粒代表了在OA治疗中持续的关节内输送的有希望的策略.
- 这种新的方法提高了OA治疗的离子疗效和作用持续时间.
- 这项研究强调了一种潜在的新疗法途径,通过以纳米粒子为基础的向药物输送来管理骨关节炎.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


